GliaPharm is a Swiss biotechnology company that develops treatments for neurological and psychiatric disorders.
GliaPharm est une entreprise suisse de biotechnologies active dans le développement de traitements de maladies neurologiques et psychiatriques.
GliaPharm Announces Research Collaboration with TRB Chemedica International
GliaPharm receives support from the FOXG1 Research Foundation and the BLACKSWAN Foundation to uncover the metabolic effect of FOXG1 in astrocytes
We made it to the @hellotmrc Global Finals of #HTChallenge! From 4,500 applications we have been named one of the 7 Industrial Biotech track Finalists competing to win at the #HTSummit! Come hear us pitch in Paris on March 14-15.